[Two breakthroughs in the treatment of type 2 diabetes. Both the receptor agonist and enzyme inhibitors now available in the clinic]

التفاصيل البيبلوغرافية
العنوان: [Two breakthroughs in the treatment of type 2 diabetes. Both the receptor agonist and enzyme inhibitors now available in the clinic]
المؤلفون: Bo, Ahrén
المصدر: Lakartidningen. 104(49-50)
سنة النشر: 2008
مصطلحات موضوعية: Vildagliptin, Dipeptidyl-Peptidase IV Inhibitors, Pyrrolidines, Venoms, Dipeptidyl Peptidase 4, Adamantane, Glucagon-Like Peptide-1 Receptor, Treatment Outcome, Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1, Nitriles, Receptors, Glucagon, Animals, Exenatide, Humans, Hypoglycemic Agents, Drug Therapy, Combination, Enzyme Inhibitors, Peptides
تدمد: 0023-7205
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::32008cb95a8f05199cab2c0f65590856Test
https://pubmed.ncbi.nlm.nih.gov/18376713Test
رقم الانضمام: edsair.pmid..........32008cb95a8f05199cab2c0f65590856
قاعدة البيانات: OpenAIRE